Sign inJoin waitlistJoin the waitlist

Faith Davies

Director, Clinical Myeloma Program, Perlmutter Cancer Center · NYU Grossman School of Medicine

Credentials: · · ·

History

Clinical Myeloma Program · NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present
NYU Grossman Long Island School of Medicine · NYU Grossman School of Medicine
Present

Hematology and Medical Oncology
1996–1999
University of Wales College of Medicine
1993–1996
Doctor of Medicine
1988–1992

Research

Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy · 2012 · 2,918 citations
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
New England Journal of Medicine · 2003 · 1,465 citations
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
Blood · 2001 · First of 17 authors · 777 citations

Gareth Morgan
295 papers
Frits van Rhee
43 papers
Maurizio Zangari
37 papers
BB
Bart Barlogie
36 papers
Carolina Schinke
34 papers
Ken Anderson
33 papers
Sharmilan Thanendrarajan
32 papers · 29 as a resident
Ola Landgren
21 papers
Saad Usmani
21 papers
FM
Francesco Maura
20 papers
Nikhil Munshi
14 papers
NR
Noopur Raje
14 papers · 9 as a resident

Grants

Investigating the Role of Incretin Mimetics in Reducing the Risk of Development and Progression of Multiple Myeloma and Its Precursor Conditions
National Cancer Institute · R21
Contact PI · $466.1K · New York University School of Medicine
2026–2028

Clinical trials

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma
Principal investigator · Withdrawn · Phase 2
University of Arkansas
2017–2019
UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination
Principal investigator · Withdrawn · Phase 2
University of Arkansas
2015–2017